Clinical Trial Update: Congenital Muscular Dystrophy Ascending Multiple Dose Cohort Study Analyzing Pharmacokinetics at Three Dose Levels In Children and Adolescents With Assessment of Safety and Tolerability of Omigapil (CALLISTO) [Phase 1]

View source ↗

Summary

Phase 1 study evaluating multiple ascending doses of omigapil in children and adolescents with congenital muscular dystrophy, focusing on pharmacokinetics and s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Muscular Dystrophy

Drugs mentioned

• omigapil (omigapil)

Snippet

Sponsor: Santhera Pharmaceuticals | Conditions: Congenital Muscular Dystrophy | Phase 1 | Status: COMPLETED | Results posted: 2019-09-20